Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telcagepant for Migraine Prophylaxis
NCT00797667Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Nov 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of telcagepant in migraine, sponsored by Merck & Co.. Started Nov 2008; status: terminated.
02
Drugs
telcagepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00797667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797667.